Evaluation of TS-1 based treatment and expression of thymidylate synthase and dihydropyrimidine dehydrogenase on oral squamous cell carcinoma

Seventeen oral squamous cell carcinoma (SCC) patients underwent chemotherapy with TS-1 (8 males and 9 females, mean age; 75.1 years, range; 47–102 years). TS-1 permitted five cases of oral chemotherapy on an outpatient basis and 8 cases in elder patients over 80-years of age. Excepting five patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oral oncology 2005-03, Vol.41 (3), p.276-282
Hauptverfasser:	Obara, Seiji, Yamamoto, Kazumi, Hosogai, Nao, Yoshimura, Yasuro
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Biomarkers, Tumor - analysis Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - enzymology Carcinoma, Squamous Cell - therapy Chemosensitivity Combined Modality Therapy Dihydropyrimidine dehydrogenase Dihydrouracil Dehydrogenase (NADP) - analysis Female Humans Immunohistochemistry Immunohistochemistry - methods Male Medical sciences Middle Aged Mouth Neoplasms - drug therapy Mouth Neoplasms - enzymology Mouth Neoplasms - therapy Oral squamous cell carcinoma Otorhinolaryngology. Stomatology Quality of Life Sensitivity and Specificity Silicates - therapeutic use Thymidylate synthase Thymidylate Synthase - analysis Titanium - therapeutic use Treatment Outcome TS-1 Tumors Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!